Skip to main content
Yingying Wang on Muck Rack

Yingying Wang

As seen in: Color Research & Application, Nature, Wiley, Wiley Online Library, Cambridge University Press & Assessment, PLOS ONE, BMJ Open, BMJ Paediatrics & Child Health, Frontiers, Frontiers in Marine Science and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingying

Contact Yingying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Shape Transformation of Ternary PtIrPd Nanocrystals with High-Index Facets via Electrodeposition and Study of Their Catalytic Activity in Alcohol Oxidation Reactions Click to copy article link Article link copied!

|
By Yingying Wang, Huizhen Dai, Kaiyu Dong
| ACS Publications
Abstract Click to copy section linkSection link copied! The catalytic activities of Pt-based nanomaterials strongly depend on their structures, including their compositions, arrangements of surface atoms, and so on. Shape-controlled synthesis has proven to be an efficient route to adjust the surface structure, while alloying has been considered an effective strategy to tune the electronic structure.
Open in Who Shared Issue with article?

Pleurotin Total Synthesis: Legacy Route and Recent Progress

|
By Yingying Wang, Bin Huang, Mengze Ruan
| Wiley Online Library Verified
, , , Pleurotin Total Synthesis: Legacy Route and Recent Progress, European Journal of Organic Chemistry2026, 0, e70648. https://doi.org/10.1002/ejoc.70648 Acknowledgments This work was supported by the National Undergraduate Training Program for Innovation and Entrepreneurship (202310285073Z, 202110285051Z), State Key Laboratory of Natural and Biomimetic Drugs (K202425), National Natural Science Foundation of China (81903442). Conflicts of Interest The authors declare no conflicts of interest.
Open in Who Shared Issue with article?

TRMT1-mediated tRNA m 2 2 G modification drives Osimertinib resistance via the ATXN3/USP25 axis in lung adenocarcinoma

|
By Jiaqi Li, Bo Jing, Yingying Wang, Wenhui Bai, Qiuyu Wei, Meng Liu, Kuofang Huang, Shifei Pan, Haijiao Lu, Jialin Qian, Yanjie Ji, Wanting Liu, Hua Zhong, Youping Zhang, Wenxuan Wu, Luo Hao, Hu Lei, Hanzhang Xu, Yingli Wu, Tianqing Chu, Chujiao Zhu, Xuxinyi Ling, Huishu Dong, Yuanhui Zhai
| Nature Verified
Abstract Acquired resistance to Osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), remains a critical challenge in lung adenocarcinoma. Here, we identify ATXN3, a deubiquitinating enzyme, as a driver of Osimertinib resistance and a predictor of poor patient survival. Osimertinib treatment dynamically upregulates ATXN3 transcription, which stabilizes USP25 through deubiquitination, activating an ATXN3-USP25-TRMT1 signaling cascade.
Open in Who Shared Issue with article?
See all 188 licensed articles (212 Total)